phase 2 trial
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
phase 2 trial
Jul 3, 2024, 02:35 |
Insight
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Absolutely abscopal…
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
May 25, 2024, 12:37 |
Blog
Neeraj Agarwal: Camrelizumab+apatinib in previously treated pts w/ advanced adrenocortical cancer by Zhigong Wei
Neeraj Agarwal shared a post on X: “Ab#4511 ASCO ASCO 24 by Zhigong Wei. Camrelizumab+apatinib ph2…
May 18, 2023, 14:56 |
Drugs
Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy
NEW: Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy showed promising activity in…
All:
4
Posts:
1 - 100
TRANSiTION - Exclusive Train the Trainers Programme 2024
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Facebook
RSS Feed
Twitter
Linkedin
Youtube